Donald Allen Williams is Director at PALISADE BIO, INC. (PALI). They have made 8 open-market trades across 2 companies since 2015, most recently 2026-10-02.
CIK 0001620013
8 open-market purchases totalling $85K since 2015, never a sale. Across 7 scored buys the stock is up 14.5% at ninety days, and 10.9 points ahead of the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| FBRX | 59,405 | $4.6M |
| PALI | 1,590,294 | $2.2M |
| ATEC | 134,728 | $1.4M |
| Total | $8.2M |
Shares reported on the most recent Form 4, priced at the 2026-10-05 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 38% | 14% | 57% |
| Avg Move | -3.2% | -7.6% | +14.5% |
| Alpha | -5.0% | -8.7% | +10.9% |
| Scored | 8 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PALI | BUY | 2026-10-01 | 2026-10-05 | $1.44 | $29K | +2.7% | — | — |
| PALI | BUY | 2026-01-16 | 2026-01-21 | $1.67 | $8K | -10.1% | -10.6% | +56.4% |
| PALI | BUY | 2026-01-09 | 2026-01-13 | $1.88 | $9K | -5.2% | -8.9% | +3.9% |
| PALI | BUY | 2024-05-28 | 2024-05-29 | $4.86 | $5K | +6.0% | +3.4% | -20.9% |
| PALI | BUY | 2024-01-31 | 2024-02-01 | $0.61 | $6K | -21.5% | -27.7% | -14.2% |
| PALI | BUY | 2023-09-27 | 2023-09-29 | $0.54 | $11K | -0.9% | -1.4% | +18.0% |
| ATEC | BUY | 2019-03-12 | 2019-03-13 | $2.47 | $10K | -2.2% | -2.9% | +63.4% |
| ATEC | BUY | 2015-05-05 | 2015-05-19 | $1.32 | $7K | +5.3% | -5.3% | -5.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.